Jasper Therapeutics, Inc. (JSPR)

CIK 1788028 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Jasper Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 4, 20268-K0001213900-26-115751
Oct 28, 2026SCHEDULE 13G0000070858-26-000538
Oct 23, 2026SC TO-I/A0001213900-26-112090
Oct 19, 2026DEF 14A0001213900-26-110751
Oct 15, 20268-K0001213900-26-109587
Oct 14, 2026S-30001213900-26-109479
Oct 9, 2026PRE 14A0001213900-26-108482
Oct 7, 2026SC TO-I0001213900-26-107397
Oct 7, 20268-K0001213900-26-107402
Oct 5, 20268-K0001213900-26-106651
Oct 5, 20268-K/A0001213900-26-106574
Oct 1, 20268-K/A0001213900-26-105924
Sep 28, 20268-K0001213900-26-104101
Sep 24, 202625-NSE0001354457-26-000914
Sep 4, 2026DEF 14A0001213900-26-097572
Aug 26, 20268-K0001213900-26-093979
Aug 24, 2026PRE 14A0001213900-26-093145
Aug 17, 2026SCHEDULE 13G0000921895-26-002220
Aug 14, 202610-Q0001213900-26-089592
Aug 14, 20268-K0001213900-26-090055
Aug 5, 2026D0001213900-26-085315
Aug 4, 202640001213900-26-085188
Aug 4, 202640001213900-26-085192
Aug 4, 202640001213900-26-085191
Aug 4, 202640001213900-26-085189